Clinical Trial Update: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial of ancrod (Viprinex) for acute ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Infarction
• Cerebral Ischemia
• Stroke

Drugs mentioned

• Viprinex (ancrod)

Snippet

Sponsor: Neurobiological Technologies | Conditions: Stroke, Cerebral Ischemia | Phase 3 | Status: TERMINATED